Odonate Therapeutics, Inc. Total Assets
Odonate Therapeutics, Inc. had Total Assets of $105.77 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2021-11-10
- 2021-09-30: Assets $105.77M.
- 2021-06-30: Assets $118.57M.
- 2021-03-31: Assets $142.88M.
- 2020-12-31: Assets $167.89M.
| Period end | Assets |
|---|---|
| 2021-09-30 | $105.77M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $118.57M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $142.88M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $167.89M 10-Q · filed 2021-11-10 |
| 2020-09-30 | $198.99M 10-Q · filed 2020-10-28 |
| 2020-06-30 | $132.73M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $161.98M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $188.83M 10-K · filed 2021-02-23 |
| 2019-09-30 | $212.79M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $214.59M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $120.47M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $142.67M 10-K · filed 2020-02-20 |
| 2018-09-30 | $166.15M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $183.01M 10-Q · filed 2018-07-30 |
| 2018-03-31 | $199.72M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $203.49M 10-K · filed 2019-02-22 |